BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1572 related articles for article (PubMed ID: 19233758)

  • 1. Cardioprotective effects of sevoflurane, isoflurane, and propofol in coronary surgery patients: a randomized controlled study.
    Yildirim V; Doganci S; Aydin A; Bolcal C; Demirkilic U; Cosar A
    Heart Surg Forum; 2009 Jan; 12(1):E1-9. PubMed ID: 19233758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sevoflurane-remifentanil versus propofol-remifentanil anesthesia at a similar bispectral level for off-pump coronary artery surgery: no evidence of reduced myocardial ischemia.
    Law-Koune JD; Raynaud C; Liu N; Dubois C; Romano M; Fischler M
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):484-92. PubMed ID: 16884977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sevoflurane on biomechanical markers of hepatic and renal dysfunction after coronary artery surgery.
    Lorsomradee S; Cromheecke S; Lorsomradee S; De Hert SG
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):684-90. PubMed ID: 17023289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of interrupted or continuous administration of sevoflurane on preconditioning before cardio-pulmonary bypass in coronary artery surgery: comparison with continuous propofol.
    Bein B; Renner J; Caliebe D; Hanss R; Bauer M; Fraund S; Scholz J
    Anaesthesia; 2008 Oct; 63(10):1046-55. PubMed ID: 18627368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of anesthetic induction agents in patients with coronary artery disease and left ventricular dysfunction.
    Singh R; Choudhury M; Kapoor PM; Kiran U
    Ann Card Anaesth; 2010; 13(3):217-23. PubMed ID: 20826962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery.
    Frässdorf J; Borowski A; Ebel D; Feindt P; Hermes M; Meemann T; Weber R; Müllenheim J; Weber NC; Preckel B; Schlack W
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1436-42, 1442.e1-2. PubMed ID: 19464461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial protection by isoflurane vs. sevoflurane in ultra-fast-track anaesthesia for off-pump aortocoronary bypass grafting.
    Hemmerling T; Olivier JF; Le N; Prieto I; Bracco D
    Eur J Anaesthesiol; 2008 Mar; 25(3):230-6. PubMed ID: 17894911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass.
    Cromheecke S; Pepermans V; Hendrickx E; Lorsomradee S; Ten Broecke PW; Stockman BA; Rodrigus IE; De Hert SG
    Anesth Analg; 2006 Aug; 103(2):289-96, table of contents. PubMed ID: 16861404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane.
    Xia Z; Huang Z; Ansley DM
    Anesth Analg; 2006 Sep; 103(3):527-32. PubMed ID: 16931656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoflurane produces only minor preconditioning in coronary artery bypass grafting.
    Wang X; Järvinen O; Kuukasjärvi P; Laurikka J; Wei M; Rinne T; Honkonen EL; Tarkka M
    Scand Cardiovasc J; 2004 Oct; 38(5):287-92. PubMed ID: 15513312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting.
    Lee MC; Chen CH; Kuo MC; Kang PL; Lo A; Liu K
    Eur J Anaesthesiol; 2006 Oct; 23(10):841-7. PubMed ID: 16507192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of isoflurane, sevoflurane, and desflurane anesthesia on neurocognitive outcome after cardiac surgery: a pilot study.
    Kanbak M; Saricaoglu F; Akinci SB; Oc B; Balci H; Celebioglu B; Aypar U
    Heart Surg Forum; 2007; 10(1):E36-41. PubMed ID: 17162400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single transpulmonary thermodilution in off-pump coronary artery bypass grafting: haemodynamic changes and effects of different anaesthetic techniques.
    Kirov MY; Lenkin AI; Kuzkov VV; Suborov EV; Slastilin VY; Borodin VV; Chernov II; Shonbin AN; Bjertnaes LJ
    Acta Anaesthesiol Scand; 2007 Apr; 51(4):426-33. PubMed ID: 17378780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial oxidative stress protection by sevoflurane vs. propofol: a randomised controlled study in patients undergoing off-pump coronary artery bypass graft surgery.
    Ballester M; Llorens J; Garcia-de-la-Asuncion J; Perez-Griera J; Tebar E; Martinez-Leon J; Belda J; Juez M
    Eur J Anaesthesiol; 2011 Dec; 28(12):874-81. PubMed ID: 21946824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal integrity in sevoflurane sedation in the intensive care unit with the anesthetic-conserving device: a comparison with intravenous propofol sedation.
    Röhm KD; Mengistu A; Boldt J; Mayer J; Beck G; Piper SN
    Anesth Analg; 2009 Jun; 108(6):1848-54. PubMed ID: 19448211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sevoflurane-fentanyl versus etomidate-fentanyl for anesthetic induction in coronary artery bypass graft surgery patients.
    Cheong KF; Choy JM
    J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):421-4. PubMed ID: 10972608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures.
    Jakobsen CJ; Berg H; Hindsholm KB; Faddy N; Sloth E
    J Cardiothorac Vasc Anesth; 2007 Oct; 21(5):664-71. PubMed ID: 17905271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients.
    Huang Z; Zhong X; Irwin MG; Ji S; Wong GT; Liu Y; Xia ZY; Finegan BA; Xia Z
    Clin Sci (Lond); 2011 Jul; 121(2):57-69. PubMed ID: 21291422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: a randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery.
    Ansley DM; Raedschelders K; Chen DD; Choi PT
    Contemp Clin Trials; 2009 Jul; 30(4):380-5. PubMed ID: 19336262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.